EMA establishes new group to counter vaccine hesitancy

The European Medicines Agency (EMA) has established a new advisory group to enhance vaccine confidence amid rising hesitancy in Europe. This group, comprising healthcare professionals, academics, and public health representatives, will meet quarterly as part of the EMA's Vaccine Outreach Strategy. Recent WHO data indicates that childhood vaccination rates remain below pre-pandemic levels, increasing vulnerability to diseases. EMA's Executive Director emphasized the importance of transparent communication to rebuild public trust in vaccines. Sanofi supports this initiative, highlighting the need for coordinated action across European Member States to combat vaccine hesitancy.